Selective Tau Imaging: Der Stand der Dinge.

Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/20481

Full metadata record

DC Field	Value	Language
dc.contributor.author	Villemagne, Victor L	-
dc.date	2017-09-21	-
dc.date.accessioned	2019-03-14T22:35:22Z	-
dc.date.available	2019-03-14T22:35:22Z	-
dc.date.issued	2018-02	-
dc.identifier.citation	Journal of Nuclear Medicine 2018; 59(2): 175-176	en
dc.identifier.uri	https://ahro.austin.org.au/austinjspui/handle/1/20481	-
dc.language.iso	eng	-
dc.subject	Alzheimer's disease	en
dc.subject	Amyloid Imaging	en
dc.subject	Molecular Imaging	en
dc.subject	Neurodegeneration	en
dc.subject	Neurology	en
dc.subject	PET	en
dc.subject	Positron emission tomography	en
dc.subject	Tau imaging	en
dc.title	Selective Tau Imaging: Der Stand der Dinge.	en
dc.type	Journal Article	en
dc.identifier.journaltitle	Journal of Nuclear Medicine	en
dc.identifier.affiliation	Molecular Imaging and Therapy	en
dc.identifier.affiliation	Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia	en
dc.identifier.affiliation	Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia	en
dc.identifier.doi	10.2967/jnumed.117.198325	en
dc.type.content	Text	en
dc.identifier.pubmedid	28935837	-
dc.type.austin	Journal Article	-
dc.type.austin	Review	-
local.name.researcher	Villemagne, Victor L
item.languageiso639-1	en	-
item.openairetype	Journal Article	-
item.fulltext	No Fulltext	-
item.grantfulltext	none	-
item.cerifentitytype	Publications	-
item.openairecristype	http://purl.org/coar/resource_type/c_18cf	-
crisitem.author.dept	Molecular Imaging and Therapy	-
Appears in Collections:	Journal articles

22

checked on May 8, 2024

Check